Advertisement
The number of American adults without health insurance has increased by about two million so far this year

American Adults Without Health Insurance Rises by Two Million

0
Losses in coverage concentrated among younger adults, people buying own health insurance policies
Patients with insurance that covers computed tomographic colonography are nearly 50 percent more likely to get screened for colorectal cancer

Screening Up When Insurance Covers CT Colonography

0
Patients whose insurance covered CT colonography were 48 percent more likely to be screened
The U.S. Food and Drug Administration has approved Endari (L-glutamine oral powder) to treat patients with sickle cell disease.

FDA Approves Endari for the Treatment of Sickle Cell Disease

0
First treatment approved for patients with sickle cell disease in almost 20 years
Patients with Parkinson's disease are about four times more likely to develop melanoma

Parkinson’s Patients Deemed at Higher Risk of Melanoma

0
Researchers urge counsel of patients that if they have one disease, they're at risk of the other
For patients with chronic hepatitis B

Subcirrhotic Liver Stiffness Cuts HCC Risk in Hepatitis B

0
Achievement of subcirrhotic range of liver stiffness with antiviral therapy reduces HCC risk
For antiphospholipid antibody carriers

Low Platelet Count Linked to Thrombosis in aPL Carriers

0
Among patients with low a-PL-S, those with low platelet count developed thrombosis more often
A high-observation protocol appears to optimize clinical care for patients with head and neck cancer undergoing primary surgery

High-Observation Protocol Cuts Length of Stay in Head, Neck CA

0
The clinical care protocol also cuts ICU admission and readmissions after primary surgery
In a case report published online June 29 in the Journal of Clinical Pharmacy and Therapeutics

Nephrotic Syndrome Reported With Everolimus, Voriconazole

0
Case report of patient with relapsed Hodgkin's lymphoma treated with everolimus for five years
An estimated two of three people in the United States have not completed an advanced directive

No Advance Directives for Almost Two-Thirds of U.S. Population

0
Among 795,909 people in 150 studies, 36.7 percent had completed an advance directive
Germline deleterious mutations are enriched among men with prostate cancer and at least one additional primary cancer

Germline Mutations Up in Men With Prostate CA, One Other CA

0
However, most of these men do not meet current clinical criteria for germline testing